Skip to content

Pilot Study of the ACE System in Lung Procedures

Pilot Study of the XACT Robotics ACE System for Image Guided Percutaneous Procedures in the Lung

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04651517
Enrollment
20
Registered
2020-12-03
Start date
2021-03-15
Completion date
2021-08-03
Last updated
2021-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Diseases

Brief summary

To evaluate the XACT ACE Robotic System in lung procedures.

Detailed description

The XACT ACE Robotic System is a user-controlled positioning system intended to assist in the planning and advancement of an instrument during Computed Tomography (CT) guided percutaneous lung procedures. The system is used for trajectory planning and is intended to assist the physician in the positioning of an instrument, such as a needle, where CT imaging is used for target trajectory planning and intraoperative tracking. This study will evaluate safety and accuracy of the XACT ACE Robotic System in subjects undergoing CT guided, minimally invasive percutaneous procedures of the lung in the interventional radiology suite.

Interventions

DEVICEXACT ACE Robotics study arm

Subjects will undergo lung procedures with the physician utilizing the XACT ACE Robotic System.

Sponsors

Xact Robotics Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Subjects 18 years of age or older who are undergoing CT guided, minimally invasive percutaneous procedures of the lung.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. 18 years of age 2. Subjects undergoing CT-guided, minimally invasive percutaneous lung procedures in the interventional radiology suite, e.g., core biopsy, fine needle aspiration (FNA), tumor ablation, etc. 3. Following planning and registration CT scans, subject is found eligible to undergo CT-guided, minimally invasive percutaneous procedure 4. Subject is willing to sign informed consent 5. Subject is capable of adhering to study procedures

Exclusion criteria

1. Subjects in whom the target is within 1 cm of a major blood vessel, major nerve or heart 2. Subject with significant coagulopathy 3. Subject with preexisting or unstable medical condition(s), which in the opinion of the investigator, might interfere with the conduct of the study 4. Subjects who are pregnant or nursing 5. Following planning and registration CT scans, required clinical trajectory to target is beyond system workspace limits (e.g., entry angle is too sharp)

Design outcomes

Primary

MeasureTime frameDescription
Adverse Events30 daysIncidence, severity, and frequency of adverse events and device-related adverse events

Secondary

MeasureTime frameDescription
Secondary Performance Evaluation - Clinical Accuracy1 hourPercent of procedures in which the needle reached the pre-defined target based on the physician's determination and CT imaging confirmation (clinical accuracy)
Secondary Performance Evaluation - System Accuracy1 hourThe measured distance from the tip of the needle/tool to the target location at the end of the needle/tip insertion.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026